Beware of antibodies to dietary proteins in "antigen-specific" immunoassays! falsely positive anticytokine antibody tests due to reactivity with bovine serum albumin in rheumatoid arthritis (The Swedish TIRA Project)

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 215-220

  Sjöwall, Christopher ^a   Kastbom, Alf ^a   Almroth, Gunnel ^a   Wetterö, Jonas ^a   Skogh, Thomas ^a  

^a Rheumatology/AIR   (Sweden)

Author keywords

Anticytokine antibodies; Bovine serum albumin; Enzyme linked immunoassay; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

BOVINE SERUM ALBUMIN; HUMAN SERUM ALBUMIN; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN INTAKE; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIBODIES; ARTHRITIS, RHEUMATOID; CATTLE; DIETARY PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; SERUM ALBUMIN, BOVINE; STATISTICS, NONPARAMETRIC;

EID: 79551704330     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100690     Document Type: Article

References (46)

1. Engvall E, Perlman P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971;8:871-4.
2. Van Weemen BK, Schuurs AH. Immunoassay using antigen-enzyme conjugates. FEBS Lett 1971;15:232-236.
3. Watanabe M, Uchida K, Nakagaki K, Trapnell BC, Nakata K. High avidity cytokine autoantibodies in health and disease: Pathogenesis and mechanisms. Cytokine Growth Factor Rev 2010;21:263-73.
4. Hesse D, Sørensen PS. Using measurements of neutralizing antibodies: the challenge of IFN-β therapy. Eur J Neurol 2007;14:850-9.
5. Taylor PC, Feldmann M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009;5:578-82.
6. Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, et al. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the Tocilizumab in Combination with Traditional Disease-modifying Antirheumatic Drug Therapy Study. Arthritis Rheum 2008;58:2968-80.
7. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009;360:2416-25.
8. Bendtzen K, Hansen MB, Ross C, Svenson M. Cytokine autoantibodies. In: Peter JB, Shoenfeldt Y, editors. Autoantibodies. Amsterdam: Elsevier; 1996:209-16.
9. Bendtzen K, Hansen MB, Ross C, Svenson M. Detection of autoantibodies to cytokines. Mol Biotechnol 2000;14:251-61.
10. Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993;13:321-8. (Pubitemid 23282028)
11. Sjöwall C, Ernerudh J, Bengtsson AA, Sturfelt G, Skogh T. Reduced anti-TNF alpha autoantibody levels coincide with flare in systemic lupus erythematosus. J Autoimmun 2004;22:315-23. (Pubitemid 38543223)
12. Kastbom A, Sjöwall C, Skogh T. Subnormal autoantibody levels to TNF alpha and IL-1 alpha are common in early rheumatoid arthritis and correlate with inflammatory activity and functional ability over time (the Swedish TIRA project) [abstract]. Arthritis Rheum 2004;50 Suppl:S354-S355.
13. Hallert E, Thyberg I, Hass U, Skargren E, Skogh T. Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis 2003;62:667-70.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
16. Panem S, Check IJ, Henriksen D, Vilcek J. Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. J Immunol 1982;129:1-3.
17. Pozzetto B, Mogensen KE, Tovey MG, Gresser I. Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease. J Infect Dis 1984;150:707-13. (Pubitemid 15200079)
18. Prümmer O, Seyfarth C, Scherbaum WA, Drees N, Porzsolt F. Interferon-alpha antibodies in autoimmune diseases. J Interferon Res 1989;9 Suppl 1:S67-74.
19. Fomsgaard A, Svenson M, Bendtzen K. Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand J Immunol 1989;30:219-23.
20. Prümmer O, Bunjes D, Wiesneth M, Arnold R, Porzsolt F, Heimpel H. High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:483-6. (Pubitemid 24295251)
21. Trown PW, Kramer MJ, Dennin RA Jr, Connell EV, Palleroni AV, Quesada J, et al. Antibodies to human leucocyte interferons in cancer patients. Lancet 1983;1:81-4.
22. Ross C, Svenson M, Hansen MB, Vejlsgaard GL, Bendtzen K. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J Clin Invest 1995;95:1974-8.
23. Satoh H, Chizzonite R, Ostrowski C, Ni-Wu G, Kim H, Fayer B, et al. Characterization of anti-IL-1 alpha autoantibodies in the sera from healthy humans. Immunopharmacology 1994;27:107-18
24. Graudal NA, Svensson M, Tarp U, Garred P, Jurik AG, Bendtzen K. Autoantibodies against interleukin-1á in rheumatoid arthritis: association with long term radiographic outcome. Ann Rheum Dis 2002;61:598-602.
25. Lindqvist E, Eberhardt K, Bendtzen K, Heinegård D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.
26. Homann C, Hansen MB, Graudal N, Hasselqvist P, Svenson M, Bendtzen K, et al. Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis. Scand J Immunol 1996;44:623-9.
27. Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum 2002;46:2384-91.
28. Elkarim RA, Dahle C, Mustafa M, Press R, Zou LP, Ekerfelt C, et al. Recovery from Guillain-Barré syndrome is associated with increased levels of neutralizing autoantibodies to interferon-γ. Clin Immunol Immunopathol 1998;88:241-8.
29. Bendtzen K, Hansen MB, Ross C, Svenson M. High-avidity autoantibodies to cytokines. Immunol Today 1998;19:209-11.
30. Galle P, Svenson M, Bendtzen K, Hansen MB. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors. Eur J Immunol 2004;34:3267-75.
31. Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, et al. Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy individuals. Blood 2009;113:2547-56.
32. Miyakawa H, Kawaguchi N, Kikuchi K, Kitazawa E, Kawashima Y, Yajima R, et al. False positive reaction in ELISA for IgM class anti-M2 antibody and its prevention. Hepatol Res 2001;20:279-87.
33. Cunningham-Rundles C, Brandeis WE, Good RA, Day NK. Milk precipitins, circulating immune complexes, and IgA deficiency. Proc Natl Acad Sci USA 1978;75:3387-9.
34. Hilger C, Grigioni F, De Beaufort C, Michel G, Freilinger J, Hentges F. Differential binding of IgG and IgA antibodies to antigenic determinants of bovine serum albumin. Clin Exp Immunol 2001;123:387-94.
35. Rothberg RM, Farr RS. Anti-bovine serum albumin and anti-alpha lactalbumin in the serum of children and adults. Pediatrics 1965;35:571-88.
36. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilahti E, et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992;327:302-7.
37. Saukkonen T, Virtanen SM, Karppinen M, Reijonen H, Ilonen J, Rasanen L, et al. Significance of cow's milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype. Childhood Diabetes in Finland Study Group. Diabetologia 1998;41:72-8.
38. Persaud DR, Barranco-Mendoza A. Bovine serum albumin and insulin-dependent diabetes mellitus; is cow's milk still a possible toxicological causative agent of diabetes? Food Chem Toxicol 2004;42:707-14.
39. Luopajärvi K, Savilahti E, Virtanen SM, Ilonen J, Knip M, Åkerblom HK, et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes 2008;9:434-41.
40. Mogues T, Li J, Coburn J, Kuter DJ. IgG antibodies against bovine serum albumin in humans - their prevalence and response to exposure to bovine serum albumin. J Immunol Methods 2005;300:1-11.
41. Lerner A, Rossi TM, Park B, Albini B, Lebenthal E. Serum antibodies to cow's milk proteins in pediatric inflammatory bowel disease: Crohn's disease vs. ulcerative colitis. Acta Paediatr Scand 1989;78:81-6.
42. Rodriguez-Juan C, Sala-Silveira L, Perez-Blas M, Valeri AP, Aguilera N, Lopez-Santalla M, et al. Increased levels of bovine serum albumin antibodies in patients with type 1 diabetes and celiac disease-related antibodies. J Pediatr Gastroenterol Nutr 2003;37:132-5.
43. Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegård J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology 2008;47:1144-50.
44. Rosenau BJ, Schur PH. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2009;36:753-6.
45. Tarkowski A, Bjursten LM, Nilsson LA, Nygren H. False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents. J Immunol Methods 1983;58:171-82. (Pubitemid 13161027)
46. Pérez-Maceda B, López-Bote JP, Langa C, Bernabeu C. Antibodies to dietary antigens in rheumatoid arthritis - possible molecular mimicry mechanism. Clin Chim Acta 1991;203:153-65.